generic drugs generic drugs
Stories About

generic drugs

Angels for Change founder Laura Bray took on the problem of drug shortages when the hospital ran out of the drug that her then-9-year-old daughter needed to treat her leukemia. Laura Bray hide caption

toggle caption
Laura Bray

The hospital ran out of her child's cancer drug. Now she's fighting to end shortages

  • Download
  • <iframe src="https://www.npr.org/player/embed/1204856094/1208066817" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Toni Dezomits' advanced ovarian cancer responded well to earlier rounds of chemo, but this spring, her doctors told her there was a shortage of a key chemo drug. Toni Dezomits hide caption

toggle caption
Toni Dezomits

Some cancer drugs are in short supply, putting patients' care at risk. Here's why

  • <iframe src="https://www.npr.org/player/embed/1181876655/1182168423" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Humira, the injectable biologic treatment for rheumatoid arthritis, now faces its first competition from one of several copycat "biosimilar" drugs expected to come to market this year. Some patients spend $70,000 a year on Humira. JB Reed/Bloomberg via Getty Images hide caption

toggle caption
JB Reed/Bloomberg via Getty Images

Generics may not have the same cost-lowering power for specialty medicines, such as multiple sclerosis drugs, researchers find. That's true especially when other brand-name drugs are approved to treat a given disease before the first generic is approved. Gary Waters/Ikon Images/Getty Images hide caption

toggle caption
Gary Waters/Ikon Images/Getty Images

A new book, Bottle of Lies, reveals serious safety and purity concerns about the global generic-drug supply. Tetra Images/Getty Images hide caption

toggle caption
Tetra Images/Getty Images

The Generic Drugs You're Taking May Not Be As Safe Or Effective As You Think

  • Download
  • <iframe src="https://www.npr.org/player/embed/723545864/724076736" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Pharmacy technician Peggy Gillespie fills a syringe with an antibiotic at ProMedica Toledo Hospital in Toledo, Ohio, in January. Tony Dejak/AP hide caption

toggle caption
Tony Dejak/AP

Drugmaker Created To Reduce Shortages And Prices Unveils Its First Products

  • Download
  • <iframe src="https://www.npr.org/player/embed/723616282/723654436" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Jose A. Bernat Bacete/Getty Images

States Sue Drugmakers Over Alleged Generic-Price-Fixing Scheme

  • Download
  • <iframe src="https://www.npr.org/player/embed/722881642/722959414" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

An FDA inspection of this Ranbaxy facility in Toansa, Punjab, India, in 2014, revealed drug quality testing violations, resulting in the FDA prohibiting Ranbaxy from marketing drugs in the U.S. that were manufactured at this plant. Dhiraj Singh/Getty Images hide caption

toggle caption
Dhiraj Singh/Getty Images

Eli Lilly and Company, based in Indianapolis, is rolling out a half-price version of its insulin Humalog that will be sold as a generic. Darron Cummings/AP hide caption

toggle caption
Darron Cummings/AP

How Much Difference Will Eli Lilly's Half-Price Insulin Make?

  • Download
  • <iframe src="https://www.npr.org/player/embed/701538016/701987150" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Though his politics are right of center and he lobbied hard against the Affordable Care Act, Republican Sen. Orrin Hatch also has been key to passing several landmark health laws with bipartisan support. Bloomberg/Getty Images hide caption

toggle caption
Bloomberg/Getty Images

How Sen. Orrin Hatch Shaped America's Health Care In Controversial Ways

  • Download
  • <iframe src="https://www.npr.org/player/embed/673851375/681125070" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Susie Christoff tried several drugs to cope with her painful psoriatic arthritis before finding Cosentyx worked the best. The problem was the cost. Chris Bartlett/for Kaiser Health News hide caption

toggle caption
Chris Bartlett/for Kaiser Health News

Why The U.S. Remains The Most Expensive Market For 'Biologic' Drugs In The World

  • Download
  • <iframe src="https://www.npr.org/player/embed/676401634/678815311" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Intermountain Healthcare, whose Intermountain Medical Center Patient Tower in Murray, Utah, is seen here, is a leader in the generic drug company being launched by hospitals. Courtesy of Intermountain Healthcare hide caption

toggle caption
Courtesy of Intermountain Healthcare

Patients with private insurance like the drug coupons because they can help make specialty medicines more affordable. But health care analysts say the coupons may also discourage patients from considering appropriate lower-cost alternatives, including generic drugs. DNY59/Getty Images hide caption

toggle caption
DNY59/Getty Images

Maryland's overturned law restricted the price of generic drugs, and had been hailed as a model for other states. It's one of a number of state initiatives designed to combat rapidly rising drug prices. Towfiqu Photography/Getty Images hide caption

toggle caption
Towfiqu Photography/Getty Images
stevecoleimages/Getty Images

Probe Into Generic Drug Price Fixing Set To Widen

  • Download
  • <iframe src="https://www.npr.org/player/embed/590217561/591423244" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Generic drugs used for other conditions are being given a second look as cancer treatments. Katherine Streeter for NPR hide caption

toggle caption
Katherine Streeter for NPR

A Pinworm Medication Is Being Tested As A Potential Anti-Cancer Drug

  • Download
  • <iframe src="https://www.npr.org/player/embed/512400204/512400205" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript